ABBOTT PARK, Ill., April 26, 2021 -- Abbott today announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe. This first-of-its-kind imaging software merges optical coherence tomography (OCT) – an imaging tool that provides physicians a comprehensive view inside an artery or blood vessel – with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians' decision-making during coronary stenting procedures. Unlike traditional imaging methods such as conventional angiography, Abbott's OCT technology uses near-infrared light to provide high-definition, precise imaging from within a blood vessel. OCT imaging also helps improve physicians' assessment of blockages in those vessels and optimize decisions related to stent selection, placement and deployment.
The equipment that surgeons use hasn't changed significantly for many decades. However, if one trial is anything to go by, clinicians could soon be taking augmented-reality glasses into the operating theatre. HoloLens, MD: Why this medical school will teach doctors anatomy with Microsoft's augmented reality, not cadavers One US university is planning on teaching the next generation of medics with the next generation of virtual reality technology. Heart surgeon Dr Maksymilian Opolski, of the Warsaw Institute of Cardiology, first tested out virtual reality glasses for a heart operation known as a PCI back in 2015, where he navigated the inside of the patient's heart using pictures projected onto the heads-up display. A PCI, short for'percutaneous coronary intervention', is a common procedure performed on people that whose coronary arteries -- the large blood vessels that provide blood to the heart -- have started to close up.
Researchers have developed a new tool for identifying the composition of arterial plaque most likely to rupture and cause a heart attack. The catheter probe combines intravascular ultrasound with fluorescence imaging to image the tiny arteries of a living heart. The new catheter can simultaneously retrieve structural and chemical information about arterial plaque, which could be used to more reliably predict heart attacks. The new device is described in a study published in the journal Scientific Reports. A currently used technique called angiography allows cardiologists to examine blood vessels for constricted regions by injecting them with a contrast agent before X-raying them.
The operating room is getting smarter, more effective--and a lot less risky for patients. Hospitals are investing in new devices, designs and digital technologies that promise a new era of innovation for surgery. The moves are part of a growing shift away from traditional open procedures that involve big incisions, lots of blood loss and long hospitalizations. They point toward a future where more patients can choose minimally invasive outpatient surgeries, with faster recoveries, fewer complications, and less pain and scarring. These new technologies cover a range of advances.
Medical devices used outside of acute care settings, such as point-of-care ultrasound, and those whose rapid development has outpaced safety assessments, namely robots, are among the top health technology hazards that nonprofit ECRI Institute has identified in a new report. Leading the organization's list, however, are accidents associated with a decades-old technology, surgical staplers. Problems associated with staplers have led FDA to propose reclassifying the devices from Class I to Class II, a higher-risk category that would allow the agency to establish special controls and labeling requirements for the devices. An advisory panel for the agency endorsed the proposal in May, and Medtronic and the Society of American Gastrointestinal and Endoscopic Surgeons both have voiced support for formal reclassification. ECRI annually compiles a list of its 10 biggest safety concerns from incident investigations and device testing as well as public and private event reporting databases.